The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

29 Nov 2013 07:00

RNS Number : 2268U
F&C Private Equity Trust PLC
29 November 2013
 



To: Stock Exchange

For immediate release:

29 November 2013

 

F&C Private Equity Trust plc

 

Quarterly results for the three months to 30 September 2013

 

· Share price total return for the quarter of 2.7 per cent for the Ordinary Shares.

 

· NAV total return for the quarter of 0.7 per cent for the Ordinary Shares.

 

 

 

Manager's Review

 

Introduction

As at 30 September 2013 the Company's net asset value ('NAV') was £193.5 million giving a fully diluted NAV per share of 264.07p, an increase over the quarter of 0.7 per cent. There were a number of significant realisations during the quarter and a number of encouraging valuation uplifts. However, there was a significant adverse contribution from currency movements during the quarter, amounting to 2.4 per cent of the NAV per share. As previously announced, an interim dividend of 5.22p per share was paid on 1 November 2013.

 

The Company had net cash of £6.4 million at the end of the period. Taking into account the accrued liability for the Zero Dividend Preference Shares of £40.9 million, this gives total net debt of £34.5 million, equivalent to a gearing level of 15.1 per cent. Since the quarter end there have been some new investments, described in detail below and, together with the payment of the interim dividend, this has led to the utilisation of the revolving credit facility for the first time since it was put in place in February 2012. At the time of writing, £3.3 million of the £50 million facility is drawn. The amount borrowed has been drawn down in Euros. The Company's total outstanding undrawn commitments at 30 September were £64.8 million of which £19 million are to funds whose investment period has expired. During the quarter, combined realisations and income totalled £9.4 million and drawdowns from funds and co-investments totalled £11.6 million.

 

New Investments

No new commitments to private equity funds were made during the quarter. Three new co-investments were added and another one has completed since the end of the period.

 

£2.7 million was invested for a 7.2 per cent stake in Recover Nordic, a Norway based but Nordic-area focused provider of damage control services, mainly to insurance companies. Typical situations of involvement for the company are weather related incidents where there has been a flooding, burst pipe or collapsed roof. This investment was led by Agilitas, an emerging manager whose principals we have known for many years.

 

We also invested £1.3 million for a stake of just under 20 per cent in Safran, a Norwegian specialist software company which provides planning software to the oil and gas and aerospace and defence industries. This investment was lead by Stavanger based boutique private equity manager Progressus.

 

£3.0 million was invested for a 6.7 per cent stake in Harrington Brooks, a provider of debt advice, debt management plans and individual voluntary arrangements and other related services. This investment was lead by our long-standing partner RJD Partners. This Manchester-based company is one of the market leaders in debt management and it is growing strongly.

 

Since the quarter end we have invested £3.0 million for an 11.2 per cent stake in Meter Provida Limited, the UK market leading distributor of gas meters to different tiers of the energy industry. There is a pending demand for smart meters which will add significantly to the company's business in the coming years. This deal was lead by emerging manager Total Capital Partners, which provides both debt and equity to growth companies.

 

Within existing fund commitments, drawdowns of £5.1 million were made during the quarter. The more notable ones once again demonstrate the sectoral and geographic spread of the portfolio, a key area of strength.

 

August Equity Partners III called £0.7 million for an investment in Minerva Education, a London based schools group. Minerva Education consists of Eaton Square School Group ('ESS') and Ravenstone School. ESS has sites in Chelsea, Pimlico, Belgravia and Knightsbridge and currently has over 650 pupils on the roll. Ravenstone School offers pre-prep and prep education from two locations in South Kensington and Marble Arch with over 100 pupils on the roll.

 

Lyceum Capital III called £0.6 million for investment in two different companies. £0.2 million went into Curocare, a UK provider of non-secure hospital and residential support for adults with learning disabilities operating nine units in total. It is expected that more will be added and further investment will be drawn as required. £0.4 million of the drawdown went towards an investment in Isotrak, an operator in the vehicle telematics industry providing vehicle tracking and fleet management software for businesses with large fleets of heavy goods and light commercial vehicles.

 

Further afield, the Company's first Poland only fund, Avallon MBO II, drew £0.5 million for its first two investments. These are Velvet Care, the former Polish subsidiary of toilet tissue and paper towels company Kimberly Clark, and ORE, a leading developer and provider of purchasing software solutions.

 

Realisations

There were a number of significant realisations during the quarter with total distributions, including income, of £9.4 million, bringing the year-to-date total to £28.4 million. The largest exit was that of fund administration company IPES, which was sold to Silverfleet. The deal had been agreed some time ago but required regulatory approval to complete. RJD Partners led this deal and the return to the Company was £1.9 million, representing a 3.1x investment multiple and a 26 per cent IRR. HusCompagniet, the Danish housebuilder, where the deal is led by FSN, is trading very well with order intake and backlog at an all time high. This has principally been due to gains in market share in Denmark and growth into neighbouring markets such as Sweden and Germany. Cash generation has been strong. In a deal led by FSN, the company returned some capital to investors through selling the preference share element of the investment to a third party investor. This yielded £1.3 million to the Company but we retain all of the equity holding and the potential for future upside. Growth Capital II distributed £0.9 million from the sale of Glasgow-based software and services company Amor to Lockheed Martin. For an integrated capital deal consisting of both debt and equity, the return of 3.6x and an IRR of 37 per cent is excellent. Warburg Pincus IX distributed £1.0 million during the quarter with £0.9 million relating to the sale of ophthalmic products company Bausch and Lomb which achieved an investment multiple of 3.5x and an IRR of 17 per cent. Lastly, TDR Capital II distributed £0.8 million following the sell-down of its position in modular building rental business Algeco Scotsman.

 

Valuation Changes

The overall net result for the quarter is a slight uplift in value. There were a number of encouraging uplifts and a smaller number of lesser downgrades. Unfortunately, however, there was a significant adverse contribution to the NAV per share of approximately 2.4 per cent from currency weaknesses. Both the euro and the US dollar weakened against sterling over the period - by 2.5 per cent and 6.3 per cent respectively.

 

The largest single uplift was £5.4 million, from venture capital fund SEP III, following the sale of a small part of its stake in flight search-engine business Skyscanner to US venture capitalist Sequoia. If, in due course, the remainder of the company is sold at a similar or higher level it will prove to be a spectacular success. More conventionally sized uplifts are associated with realisations which happened before or immediately after the quarter end. Growth Capital II was up by £0.6 million as a result of the sale of Amor referred to above, Primary Capital III was uplifted by £0.6 million reflecting a partial realisation from Leisure Pass Group, the visitor attractions passes and systems company, and Alchemy Special Opportunities Fund was up by £0.4 million reflecting the strong post-flotation progress of the share price of Countrywide and the locking in of this gain through a sale in the market late in the quarter.

 

A welcome development has been the return of uplifts in the Iberian element of the portfolio, with N+1 Private Equity Fund II announcing the sale of Mivisa, the manufacturer of tin can packaging to Crown Holdings of the US, achieving a 2.3x multiple, a 35 per cent IRR and an associated uplift of £0.4 million, and Portobello Capital II making several trading based uplifts collectively totalling £0.3 million. There was also an encouraging development in Italian fund Alto Capital II which has announced the sale of Italian coffee machine manufacturer Rancilio, which resulted in an uplift of £0.4 million.

 

In terms of downgrades, Life Science Partners III was devalued by £1.1 million principally because its recently-floated holding, Prosensa, has seen a sharp share price fall following disappointing phase III results for its lead product Drisapersen (therapy for Duchenne muscular dystrophy). With its partner GSK it will be continuing to progress this product, but in the short term this is a significant blow. The Nordic region has been generally positive but this quarter Procuritas Capital IV was down by £0.6 million due to poor performance of two holdings. One of the portfolio's older holdings, Candover 2005, was down by £0.4 million mainly due to weaker trading in Dutch technical services business Stork.

 

Financing

At the end of the period the Company had net cash of £6.4 million and the full £50 million of the revolving credit facility available. Since the quarter end we have funded both the interim dividend and the Meter Provida Limited co-investment, as well as 'ordinary' drawdowns, such that we have utilised £3.3 million of the facility. The rate of drawdown can be expected to tail off over the next few months as the older funds' investment periods progressively expire and the newer commitments, which are smaller, invest steadily as market conditions allow. The co-investment component of the portfolio is being deliberately increased and we will continue with this strategy whilst managing the Company's resources prudently. It is our expectation that we will build surplus cash as we progress through 2014 and that this, combined with some of the borrowing facility, can be used to redeem the Zero Dividend Preference Shares in December 2014.

 

Outlook

The Company has a very broad portfolio and this historically has proved to be a key strength. Most of the portfolio is invested in European mid-market buyout funds and, accordingly, the conditions in the various European private equity and debt markets are important. The general picture is of modest growth and recovering confidence with this being more evident in the north of the Continent rather than the south. There are always examples which disprove such generalisations and this quarter has included several. The principal commodity on which we rely is the human capital of our investment partners and it is in assessing this that most of our effort is expended. In recent years very few managers have avoided portfolio difficulties completely and there has been a consequent process of differentiation taking place between the successful and the others. It is vital that we comprehensively and fairly judge each fund and its managers before allocating capital to new funds and co-investments. Our belief is that to sustain premium rather than average returns it is also important that emerging managers, who may prove to be the champions of the future, are also selectively backed.

 

 

Hamish Mair

Investment Manager

F&C Investment Business Limited

 

F&C Private Equity Trust plc

 

Consolidated Statement of Comprehensive Income for the

nine months ended 30 September 2013

 

(Unaudited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Income

Gains on investments held at fair value

-

14,783

14,783

Exchange losses

-

(28)

(28)

Investment income

1,659

-

1,659

Other income

32

-

32

Total income

1,691

14,755

16,446

Expenditure

Investment management fee

(383)

(1,149)

(1,532)

Other expenses

(526)

-

(526)

Total expenditure

(909)

(1,149)

(2,058)

Profit before finance costs and taxation

782

13,606

14,388

Finance costs

(205)

(3,324)

(3,529)

Profit before taxation

577

10,282

10,859

Taxation

(150)

150

-

Profit for period/total comprehensive income

427

10,432

10,859

Return per Ordinary Share - Basic

0.59p

14.43p

15.02p

Return per Ordinary Share - Fully diluted

0.58p

14.05p

14.63p

Return per Restricted Voting Share - Basic

(0.01)p

0.01p

-

 

 

F&C PRIVATE EQUITY TRUST PLC

 

Consolidated Statement of Comprehensive Income for the

nine months ended 30 September 2012

 

 

(Unaudited)

 

Revenue

£'000

 

Capital

£'000

 

Total

£'000

Income

Gains on investments held at fair value

-

8,588

8,588

Exchange gains

-

187

187

Investment income

2,733

-

2,733

Other income

15

-

15

Total income

2,748

8,775

11,523

Expenditure

Investment management fee

(364)

(1,093)

(1,457)

Other expenses

(617)

-

(617)

Total expenditure

(981)

(1,093)

(2,074)

Profit before finance costs and taxation

1,767

7,682

9,449

Finance costs

(218)

(3,133)

(3,351)

Profit before taxation

1,549

4,549

6,098

Taxation

(439)

431

(8)

Profit for period/total comprehensive income

1,110

4,980

6,090

Return per Ordinary Share - Basic

0.84p

7.70p

8.54p

Return per Ordinary Share - Fully diluted

0.82p

7.50p

8.32p

Return per Restricted Voting Share - Basic

0.75p

(0.88)p

(0.13)p

 

 

 

 

F&C Private Equity Trust plc

 

Consolidated Statement of Comprehensive Income for the

year ended 31 December 2012

 

(Audited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Income

Gains on investments held at fair value

-

15,178

15,178

Exchange gains

-

176

176

Investment income

4,044

-

4,044

Other income

25

-

25

Total income

4,069

15,354

19,423

Expenditure

Investment management fee

(487)

(1,462)

(1,949)

Other expenses

(866)

-

(866)

Total expenditure

(1,353)

(1,462)

(2,815)

Profit before finance costs and taxation

2,716

13,892

16,608

Finance costs

(283)

(4,198)

(4,481)

Profit before taxation

2,433

9,694

12,127

Taxation

(615)

622

7

Profit for year/total comprehensive income

1,818

10,316

12,134

Return per Ordinary Share - Basic

1.81p

15.08p

16.89p

Return per Ordinary Share - Fully diluted

1.76p

14.68p

16.44p

Return per Restricted Voting Share - Basic

0.76p

(0.87)p

(0.11)p

 

 

F&C Private Equity Trust plc

 

Amounts Recognised as Dividends

 

 

 

 

Nine months ended

30 September 2013 (unaudited)

£'000

Nine months ended

30 September 2012 (unaudited)

£'000

Year

ended

31 December 2012 (audited)

£'000

Final Ordinary Share dividend of 0.80p per share for the year ended 31 December 2011

 

-

 

578

 

578

Interim Ordinary Share dividend of 4.96p per share for the year ended 31 December 2012

 

-

 

-

 

3,585

Final Ordinary Share dividend of 5.07p per share for the year ended 31 December 2012

 

3,665

 

-

 

-

 

3,665

578

4,163

 

 

On 27 January 2012 a special dividend of 1.60p per Restricted Voting Share was paid. The total amount paid was £1,073,000.

 

On 28 September 2012 a special dividend of 3.30p per Restricted Voting Share was paid. The total amount paid was £2,214,000.

 

On 14 February 2013 a final Restricted Voting Shares dividend of 1.675p per Restricted Voting Share was paid. The total amount paid was £1,124,000.

 

F&C Private Equity Trust plc

 

Consolidated Balance Sheet

 

As at 30 September 2013

(unaudited)

As at 30 September 2012(unaudited)As at 31 December 2012

(audited)

£'000

£'000

 £'000

Non-current assets

Investments at fair value through profit or loss

229,003

212,449

213,662

Current assets

Other receivables

350

477

464

Cash and short-term deposits

6,434

10,745

12,931

6,784

11,222

13,395

Current liabilities

Other payables

(1,406)

(1,398)

(1,453)

Net current assets

5,378

9,824

11,942

Total assets less current liabilities

234,381

222,273

225,604

Non-current liabilities

Zero dividend preference shares

(40,880)

(37,301)

(38,173)

Net assets

193,501

184,972

187,431

Equity

Called-up ordinary share capital

723

1,394

1,394

Special distributable capital reserve

15,679

15,679

15,679

Special distributable revenue reserve

31,403

32,527

32,527

Capital redemption reserve

1,335

664

664

Capital reserve

141,968

133,450

135,201

Revenue reserve

2,393

1,258

1,966

Shareholders' funds

193,501

184,972

187,431

Net asset value per Ordinary Share - Basic

267.70p

254.37p

257.75p

Net asset value per Ordinary Share - Fully diluted

 

264.07p

 

251.08p

 

254.38p

Net asset value per Restricted Voting Share - Basic

 

n/a

 

1.66p

 

1.67p

 

F&C Private Equity Trust plc

Reconciliation of Movements in Shareholders' Funds

 

 

 

 

 

Nine months ended 30 September 2013

Nine months ended 30 September 2012

Year

ended 31 December 2012

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Opening shareholders' funds

187,431

182,747

182,747

Profit for the period/total comprehensive income

10,859

6,090

12,134

Dividends paid (Ordinary Shares)

(3,665)

(578)

(4,163)

Special dividends paid (Restricted Shares)

(1,124)

(3,287)

(3,287)

Closing shareholders' funds

193,501

184,972

187,431

 

  

Notes (unaudited)

 

1. The unaudited quarterly results have been prepared on the basis of the accounting policies set out in the statutory accounts of the Group for the year ended 31 December 2012.

 

2. Earnings for the nine months to 30 September 2013 should not be taken as a guide to the results for the year to 31 December 2013.

 

3. Investment management fee:

 

 

 

Nine months ended

30 September 2013

 

 

Nine months ended

30 September 2012

 

 

Year ended

31 December 2012

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Investment management fee

383

1,149

1,532

364

1,093

1,457

487

1,462

1,949

 

 

 

 

 

 

 

 

 

 

 

383

1,149

1,532

364

1,093

1,457

487

1,462

1,949

 

 

 

 

 

 

 

 

 

 

 

4. Finance costs:

 

 

 

Nine months ended

30 September 2013

 

 

Nine months ended

30 September 2012

 

 

Year ended

31 December 2012

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Interest payable on bank loans and overdrafts

 

205

 

617

 

822

 

218

 

654

 

872

 

283

 

847

 

1,130

Finance costs attributable to ZDP Shares

 

-

 

2,707

 

2,707

 

-

 

2,479

 

2,479

 

-

 

3,351

 

3,351

 

 

 

 

 

 

 

 

 

 

 

205

3,324

3,529

218

3,133

3,351

283

4,198

4,481

 

 

 

 

 

 

 

 

 

 

 

5. The basic return per Ordinary Share is based on a net return on ordinary activities after taxation of £10,859,000 (30 September 2012 - £6,175,000; 31 December 2012 - £12,207,000) and on 72,282,273 (30 September 2012 - 72,282,273; 31 December 2012 - 72,282,273) shares, being the weighted average number of Ordinary Shares in issue during the period.

 

The fully diluted return per Ordinary Share is based on a net return on ordinary activities after taxation of £10,859,000 (30 September 2012 - £6,175,000; 31 December 2012 - £12,207,000) and on 74,241,429 (30 September 2012 - 74,241,429; 31 December 2012 - 74,241,429) shares, being the weighted average number of Ordinary Shares in issue during the period after conversion of the Ordinary Share warrants.

 

The basic return per Restricted Voting Share is based on a net loss on ordinary activities after taxation of £nil (30 September 2012 - loss £85,000; 31 December 2012 - loss £73,000) and on 67,084,807 (30 September 2012 - 67,084,807; 31 December 2012 - 67,084,807) shares, being the weighted average number of Restricted Voting Shares in issue during the period.

 

6.  Zero Dividend Preference Shares

The Zero Dividend Preference Shares ('ZDP Shares') of F&C Private Equity Zeros plc were issued on 14 December 2009 at 100p per share and redeem on 15 December 2014 at 152.14p per share, an effective rate of 8.75 per cent per annum.

 

 

 

 

 

The fair value of the ZDP Shares at 30 September 2013 was £43,350,000 based on the quoted price of 144.50p per ZDP Share.

 

 

 

Number of ZDP Shares

Amount due to ZDP shareholders £'000

As at 31 December 2012

30,000,000

38,173

ZDP Shares finance cost

-

2,707

As at 30 September 2013

30,000,000

40,880

 

7. The basic net asset value per Ordinary Share is based on net assets at the period end of £193,501,000 (30 September 2012 - £183,861,000; 31 December 2012 - £186,308,000) and on 72,282,273 (30 September 2012 - 72,282,273; 31 December 2012 - 72,282,273) shares, being the number of Ordinary Shares in issue at the period end.

 

The fully diluted net asset value per Ordinary Share is based on net assets at the period end of £196,047,000 (30 September 2012 - £186,407,000; 31 December 2012 - £188,854,000) and on 74,241,429 (30 September 2012 - 74,241,429; 31 December 2012 - 74,241,429) shares, being the number of Ordinary Shares in issue at the period end after conversion of the Ordinary Share warrants.

 

8. Following the payment of the final Restricted Voting Shares dividend of 1.675p per share on 14 February 2013, the Restricted Voting Pool has no assets or liabilities. The Restricted Voting Shares were converted and re-designated as Deferred Shares on 14 February 2013 and the Deferred Shares were bought back by the Company and cancelled on that date. On 15 February 2013 the admission of the Restricted Voting Shares to the Official List of the UKLA and trading on the London Stock Exchange's Main Market were cancelled. The Company therefore no longer has any Restricted Voting Shares in issue.

 

9. The financial information for the nine months ended 30 September 2013, which has not been audited or reviewed by the Company's auditors, comprises non-statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2012, on which the auditors issued an unqualified report, have been lodged with the Registrar of Companies. The quarterly report is available at the Company's website www.fcpet.co.uk.

 

 

 

For more information, please contact:

 

Hamish Mair (Investment Manager)

0131 718 1184

hamish.mair@fandc.com

 

Gordon Hay Smith (Company Secretary)

0131 718 1018

gordon.haysmith@fandc.com

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTEAKFPALXDFFF
Date   Source Headline
30th Jun 20223:22 pmRNSChange of Name
17th Jun 20224:07 pmRNSTransaction in Own Shares
15th Jun 20225:01 pmRNSTransaction in Own Shares
27th May 20229:08 amRNSResult of Annual Gen Meeting & Directorate Change
26th May 202212:02 pmRNS1st Quarter Results
27th Apr 202210:07 amRNSDirector/PDMR Shareholding
27th Apr 202210:06 amRNSDirector/PDMR Shareholding
27th Apr 202210:04 amRNSDirector/PDMR Shareholding
26th Apr 20223:24 pmRNSDirector/PDMR Shareholding
26th Apr 20223:23 pmRNSDirector/PDMR Shareholding
25th Apr 20229:24 amRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
1st Apr 202210:17 amRNSHolding(s) in Company
1st Apr 202210:09 amRNSHolding(s) in Company
30th Mar 20222:56 pmRNSDirector/PDMR Shareholding
30th Mar 20222:54 pmRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSAnnual Financial Report
17th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSUpdate on Secondary Placing
13th Jan 20227:00 amRNSProposed Secondary Placing
4th Jan 20227:00 amRNSInvestor Presentation
26th Nov 20217:00 amRNS3rd Quarter Results
22nd Nov 202110:47 amRNSHolding(s) in Company
15th Oct 20219:55 amRNSHolding(s) in Company
15th Oct 20217:00 amRNSKepler Trust Intelligence: New Research
27th Aug 20217:00 amRNSInterim results and Quarterly Dividend
25th Jun 20213:14 pmRNSHolding(s) in Company
27th May 20212:15 pmRNSAGM Statement
27th May 202111:51 amRNSQuarterly NAV and Dividend Announcement
29th Apr 20211:01 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSAnnual Financial Report
26th Mar 20217:00 amRNSFinal Results
24th Mar 20217:00 amRNSInvestment Update
8th Feb 20213:00 pmRNSHolding(s) in Company
9th Dec 20209:22 amRNSHolding(s) in Company
27th Nov 202010:52 amRNSHolding(s) in Company
25th Nov 20209:18 amRNSKepler Trust Intelligence: New Research
20th Nov 20207:00 amRNSQuarterly results and dividend announcement
15th Oct 20204:09 pmRNSNon-Executive Director Declaration
18th Sep 20202:09 pmRNSDirector/PDMR Shareholding
16th Sep 20202:24 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSInterim Results
20th Jul 20207:00 amRNSNon-Executive Director Declaration
17th Jul 20207:00 amRNSAppointment of Corporate Broker
9th Jun 20209:57 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSDirectorate Change
22nd May 20204:11 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFirst Quarter Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.